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Urinary excretion of oxalate is one of risk factors in urinary stone formation. Prevention of undesirable
overﬂow into the production of oxalate deﬁnitely leads to a decrease of urolithiasis. The activity of serine :
pyruvate/alanine : glyoxylate aminotransferase (SPT/AGT) or glyoxylate reductase/hydroxypyruvate
reductase (GRHPR), the key enzyme of primary hyperoxlauria type 1 and 2, respectively, and their
subcellular distribution highly affects the oxalate production. On the other hand, urolithiasis is tightly
related to lifestyle disease, such as diabetes mellitus and insulin resistance. The hypothesis that insulin
resistance induces mitochondria dysfunction, resulting in the decrease of mitochondria-related enzyme
activity is a very attractive new treatment strategy of urolithiasis. Namely, the improvement of insulin
resistance might prevent stone formation.
(Hinyokika Kiyo 57 : 39-41, 2011)
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Fig. 2. SPT/AGT の種特異的，食習性依存性細
胞内局在.
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